Asia-Pacific Journal of Clinical Oncology
Article . 2014 . Peer-reviewed
License: Wiley TDM
Data sources: Crossref
The PHLDB1 rs498872 (11q23.3) polymorphism and glioma risk: A meta-analysis
rs498872 polymorphism and glioma risk
Xingchun Gao; Yajing Mi; Aili Yan; Baoyong Sha; Na Guo; Zhifang Hu; Ni Zhang; Fengliang Jiang; Xingchun Gou;
doi: 10.1111/ajco.12211
The PHLDB1 rs498872 (11q23.3) polymorphism and glioma risk: A meta-analysis
Related Organizations
- Institute of Basic Medical Sciences and Peking Union Medical College Hospital, Chinese Academy of Medical Sciences / Peking Union Medical College. China (People's Republic of)
- Xi'an Medical University China (People's Republic of)
6 Research products, page 1 of 1
- 2014IsAmongTopNSimilarDocuments
- 2017IsAmongTopNSimilarDocuments
- 2016IsAmongTopNSimilarDocuments
- 2019IsAmongTopNSimilarDocuments
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).10 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
citations
Citations provided by BIP!
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
popularity
Popularity provided by BIP!
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
10
Average
Average
Top 10%
bronze
